PATENT CLAIM ANALYSIS

Application Number: 16081260
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["544", "239000"]

Abstract:
The present invention provides an agent for treating malignant tumor, comprising a compound of formula (1): wherein R 1  to R 4  are hydrogen atom, halogen, or etc., Y is optionally-substituted alkylene group or etc.

Claim (Index 6):
The compound of  claim 1  or a pharmaceutically acceptable salt thereof, wherein a carbon atom of the alkylene or alkenylene group in Y is substituted with one or two substituents selected independently from the group consisting of C 1-4  alkyl group and halogenated C 1-4  alkyl group, further when the carbon atom is substituted with two substituents, each substitutable carbon atom in the two substituents may be combined together to form a 3- to 6-membered carbon ring.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.16216
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12739262', '13796437', '13388884', '10472412', '13800907']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8092458838093365
- 35 USC 102 Novelty (BERT): 0.5281503568733621
- Combined Prediction Score: 0.7811363311157391
- Mean Citation Score: 330.37364
- Max Citation Score: 345.36115
- Similarity Product: 243.94808134432137

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test